News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,413 Results
Type
Article (44022)
Company Profile (320)
Press Release (692058)
Multimedia
Podcasts (92)
Webinars (19)
Section
Business (208107)
Career Advice (2274)
Deals (36000)
Drug Delivery (116)
Drug Development (82499)
Employer Resources (182)
FDA (16540)
Job Trends (15215)
News (351898)
Policy (33263)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2649)
Accelerated approval (32)
Adcomms (25)
Allergies (144)
Alliances (50682)
ALS (175)
Alzheimer's disease (1692)
Antibody-drug conjugate (ADC) (318)
Approvals (16790)
Artificial intelligence (530)
Autoimmune disease (156)
Automation (39)
Bankruptcy (367)
Best Places to Work (11759)
BIOSECURE Act (21)
Biosimilars (193)
Biotechnology (216)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (646)
Cancer (4876)
Cardiovascular disease (410)
Career advice (1922)
Career pathing (38)
CAR-T (291)
CDC (47)
Celiac Disease (2)
Cell therapy (771)
Cervical cancer (36)
Clinical research (70395)
Collaboration (1760)
Company closure (4)
Compensation (1166)
Complete response letters (62)
COVID-19 (2770)
CRISPR (93)
C-suite (868)
Cystic fibrosis (143)
Data (6286)
Decentralized trials (2)
Denatured (28)
Depression (138)
Diabetes (506)
Diagnostics (6780)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (192)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90828)
Editorial (65)
Employer branding (21)
Employer resources (158)
Events (120543)
Executive appointments (996)
FDA (19682)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1503)
Gene editing (205)
Generative AI (46)
Gene therapy (623)
GLP-1 (988)
Government (4736)
Grass and pollen (6)
Guidances (383)
Healthcare (19094)
HIV (59)
Huntington's disease (46)
IgA nephropathy (84)
Immunology and inflammation (265)
Immuno-oncology (63)
Indications (111)
Infectious disease (3044)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (253)
Interviews (380)
IPO (16799)
IRA (52)
Job creations (3797)
Job search strategy (1601)
JPM (61)
Kidney cancer (17)
Labor market (86)
Layoffs (559)
Leadership (36)
Legal (8093)
Liver cancer (91)
Longevity (15)
Lung cancer (656)
Lymphoma (381)
Machine learning (44)
Management (60)
Manufacturing (817)
MASH (165)
Medical device (13835)
Medtech (13888)
Mergers & acquisitions (20276)
Metabolic disorders (1293)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (322)
Neuropsychiatric disorders (92)
Neuroscience (2951)
Neurotech (1)
NextGen: Class of 2026 (6646)
Non-profit (4574)
Now hiring (67)
Obesity (611)
Opinion (292)
Ovarian cancer (166)
Pain (200)
Pancreatic cancer (231)
Parkinson's disease (283)
Partnered (34)
Patents (503)
Patient recruitment (496)
Peanut (57)
People (60175)
Pharmaceutical (69)
Pharmacy benefit managers (30)
Phase 1 (22028)
Phase 2 (31012)
Phase 3 (22985)
Pipeline (5313)
Policy (292)
Postmarket research (2584)
Preclinical (9380)
Press Release (71)
Prostate cancer (241)
Psychedelics (50)
Radiopharmaceuticals (282)
Rare diseases (861)
Real estate (6159)
Recruiting (75)
Regulatory (24876)
Reports (53)
Research institute (2464)
Resumes & cover letters (377)
Rett syndrome (27)
RNA editing (17)
RSV (77)
Schizophrenia (152)
Series A (247)
Series B (199)
Service/supplier (11)
Sickle cell disease (100)
Special edition (23)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3748)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (88)
The Weekly (62)
Vaccines (1028)
Venture capital (93)
Weight loss (395)
Women's health (91)
Worklife (18)
Date
Last 7 days (615)
Last 30 days (2093)
Last 365 days (30346)
2026 (3482)
2025 (30764)
2024 (35736)
2023 (40536)
2022 (51755)
2021 (56257)
2020 (54672)
2019 (47212)
2018 (35603)
2017 (32777)
2016 (32324)
2015 (38253)
2014 (32030)
2013 (27105)
2012 (29396)
2011 (30039)
2010 (28091)
Location
Africa (801)
Alabama (83)
Alaska (7)
Arizona (314)
Arkansas (13)
Asia (40471)
Australia (6763)
California (11421)
Canada (3296)
China (1128)
Colorado (483)
Connecticut (483)
Delaware (339)
Europe (88117)
Florida (1690)
Georgia (360)
Hawaii (3)
Idaho (61)
Illinois (891)
India (65)
Indiana (522)
Iowa (23)
Japan (434)
Kansas (130)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1389)
Massachusetts (8214)
Michigan (326)
Minnesota (633)
Mississippi (5)
Missouri (128)
Montana (35)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3034)
New Mexico (30)
New York (3008)
North Carolina (1488)
North Dakota (10)
Northern California (5585)
Ohio (336)
Oklahoma (21)
Oregon (41)
Pennsylvania (2298)
Puerto Rico (24)
Rhode Island (48)
South America (1182)
South Carolina (66)
South Dakota (1)
Southern California (4433)
Tennessee (176)
Texas (1758)
United States (40514)
Utah (341)
Vermont (1)
Virginia (264)
Washington D.C. (82)
Washington State (940)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
736,413 Results for "turn biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences
February 10, 2026
·
3 min read
Press Releases
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
January 8, 2026
·
4 min read
Mergers & acquisitions
JPM26: Galapagos’ New CEO Is Here To Finally Turn the Ship Around
Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of years of turmoil.
January 19, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership
October 1, 2025
·
5 min read
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
The back-heavy deal includes a $5 million upfront payment for two novel T cell engagers, though the companies have yet to disclose priority indications.
November 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
·
5 min read
Alzheimer’s disease
I Remember Aduhelm. The Return of Roche in Alzheimer’s Is a Turning Point
After covering the Alzheimer’s space through every high and low,
BioSpace
’s Annalee Armstrong welcomes back Roche for the 2026 Alzheimer’s Renaissance.
December 2, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Turn Therapeutics Appoints Arthur Golden to Board of Directors
October 15, 2025
·
4 min read
Press Releases
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 14, 2025
·
7 min read
1 of 73,642
Next
